Skip to main content

Clinical Trials Using Tretinoin

Review the clinical trials studying tretinoin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-7 of 7

Tretinoin and Arsenic Trioxide with or without Gemtuzumab Ozogamicin in Treating Patients with Previously Untreated Acute Promyelocytic Leukemia
Status: Active
Location: 5 locations
Implantable Microdevice for Evaluating Drug Responses in Patients with Head and Neck Cancers, the Window of Opportunity Study
Status: Active
Location: 2 locations
Tretinoin and Retifanlimab in Treating Patients with Recurrent IDH-Mutant Glioma
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Pembrolizumab and All-Trans Retinoic Acid for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma and B Non-Hodgkin Lymphoma
Status: Active
Location: Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
All-Trans Retinoic Acid and Cemiplimab for the Treatment of Patients with Metastatic or Locally Advanced, Unresectable Leiomyosarcoma
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Topical Tretinoin for the Prevention of Anti-EGFR Induced Skin Toxicity in Patients Undergoing Treatment for Metastatic Colorectal Cancer
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah